KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Notes Payables (2018 - 2025)

Aurora Cannabis has reported Notes Payables over the past 8 years, most recently at $44.3 million for Q4 2025.

  • Quarterly Notes Payables fell 23.5% to $44.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.3 million through Dec 2025, down 23.5% year-over-year, with the annual reading at $28.0 million for FY2025, 51.08% down from the prior year.
  • Notes Payables was $44.3 million for Q4 2025 at Aurora Cannabis, up from $43.4 million in the prior quarter.
  • Over five years, Notes Payables peaked at $57.9 million in Q4 2024 and troughed at $7.1 million in Q1 2023.
  • The 5-year median for Notes Payables is $39.4 million (2024), against an average of $36.8 million.
  • Year-over-year, Notes Payables plummeted 76.81% in 2021 and then surged 448.87% in 2024.
  • A 5-year view of Notes Payables shows it stood at $42.6 million in 2021, then plummeted by 37.47% to $26.6 million in 2022, then surged by 79.89% to $47.9 million in 2023, then grew by 20.84% to $57.9 million in 2024, then decreased by 23.5% to $44.3 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Notes Payables are $44.3 million (Q4 2025), $43.4 million (Q3 2025), and $43.2 million (Q2 2025).